For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230213:nRSM7698Pa&default-theme=true
RNS Number : 7698P Royal Bank of Canada 13 February 2023
Regulatory Announcement
Royal Bank of Canada
February 13, 2023
Publication of Prospectus
Not for release, publication or distribution, directly or indirectly, in or
into the United States.
Notice to Noteholders and Publication of Amended and Restated Final Terms
Royal Bank of Canada has today given notice to Noteholders relating to the
issue of AUD50,000,000 6.005 per cent. Notes due February 8, 2038, Series
67695 (ISIN XS2584499599) issued on February 7, 2023 (the "Notes") pursuant to
its Programme for the Issuance of Securities (the "Programme").
Noteholders have been informed that pursuant to Condition 14 (fourth
paragraph, item (ii) of the first sentence), the Final Terms dated February 3,
2023 relating the Notes have been amended and restated on February 13, 2023 to
cure a manifest error in the Notes (the "Amended and Restated Final Terms").
Item 14(vi) (Fixed Coupon Amount) has been amended to read "AUD12,010" instead
of "AUD12,100".
All other Conditions remain unchanged.
The Issuer has today published the Amended and Restated Final Terms and
submitted them to the London Stock Exchange. They are available to view
at http://www.rns-pdf.londonstockexchange.com/rns/7698P_1-2023-2-13.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7698P_1-2023-2-13.pdf)
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus dated July 29,
2022, as supplemented by the 1(st) Supplementary Notes Base Prospectus dated
August 25, 2022 and the 2(nd) Supplementary Notes Base Prospectus dated
December 20, 2022 relating to the Programme (the "Prospectus") and the Amended
and Restated Final Terms, may be addressed to and/or targeted at persons who
are residents of particular countries (specified in the Prospectus) only and
is not intended for use and should not be relied upon by any person outside
these countries and/or to whom the offer contained in the Amended and Restated
Final Terms is not addressed. Prior to relying on the information contained
in the Final Amended and Restated Terms you must ascertain from the
Prospectus, as supplemented by these Amended and Restated Final Terms, whether
or not you are part of the intended addressees of the information contained
therein.
The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") and are subject to
US tax law requirements. Subject to certain exceptions, the Notes may not be
offered, sold or delivered in or into the United States or to or for the
account or benefit of US persons (as defined in Regulation S under the
Securities Act). No public offering of the Notes is being made in the United
States. This announcement does not constitute an offer to sell or a
solicitation to buy securities in the United States or in any other
jurisdiction where such offer or solicitation would be unlawful.
Your right to access this service is conditional upon complying with the above
requirement.
UK MiFIR professionals / ECPs-only / No PRIIPs KID - Manufacturer target
market (UK MiFIR Product Governance) is eligible counterparties and
professional clients only (all distribution channels). No PRIIPs key
information document (KID) has been prepared as not available to retail in EEA
and the UK.
To view the full document, please paste the following URLs into the address
bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/7698P_1-2023-2-13.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7698P_1-2023-2-13.pdf)
For further information, please contact
Erin Dion
Assistant General Counsel
Royal Bank of Canada
Telephone Number: (416) 974-4103
Fax Number: (416) 955-2032
Email: erin.dion@rbc.com
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PDIMZGMZVFVGFZM